Loading organizations...
Loading organizations...
Develops therapeutic drug candidates for skin diseases.
Alphyn Biologics has raised $28.3M across 2 funding rounds.
Alphyn Biologics has raised $28.3M in total across 2 funding rounds.
Alphyn Biologics has raised $28.3M in total across 2 funding rounds.
Alphyn Biologics's investors include Tony Shipley, Angel Physicians Fund, Serial Stage Venture Partners, Queen City Angels.
Alphyn Biologics has raised $28.3M across 2 funding rounds. Most recently, it raised $25.0M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 12, 2025 | $25.0M Series B | Tony Shipley | Angel Physicians Fund, Serial Stage Venture Partners |
| Sep 19, 2022 | $3.3M Series A | Queen City Angels | Angel Physicians Fund, Serial Stage Venture Partners |